Search

everythinglearnresearchcommunity

for

Search:↓

Differences in androgen receptor expression and tissue properties may lead to higher cryptorchidism risk in certain rats.

DHT deficiency may disrupt rat epididymis function by affecting estrogen receptors.

A new mutation linked to partial Androgen Insensitivity Syndrome and prostate cancer was found in a patient unhappy with their female gender assignment.

VEGF and its receptor might cause hair loss.

Different substances that activate or block the androgen receptor can affect male development and treat conditions like prostate cancer.

Androgen receptors play a key role in male development and prostate cancer, with treatments targeting androgen action.

The document concludes that antiandrogenic drugs like cyproterone acetate and spironolactone are effective but not permanent treatments for skin-related androgenization in women.

Teicoplanin may help treat hair loss by reducing androgen receptors and boosting hair cell growth.

Blocking androgen receptors boosts macrophages' ability to clear certain bacteria.

Targeting androgen receptor signaling may improve acute myeloid leukemia treatment.

A new method helps detect androgen receptor movement in cells, aiding research on hair loss treatments.

Blocking glucocorticoid receptors improves glucose metabolism in a PCOS mouse model.

Androgens may improve pig reproduction by enhancing ovulation and litter size.

Opioid use may lower PSA levels, suggesting a possible role in prostate cancer control; PSA testing is useful for detecting prostate cancer; serum triglycerides are not linked to prostate cancer risk; and higher urethral PSA levels may be associated with local hormone activity.

cp-asiAR may effectively treat androgenetic alopecia by promoting hair growth and reducing androgen receptor activity.

cp-asiAR may effectively treat hair loss by targeting androgen receptors.

Higher levels of heat shock protein 27 and lower levels of miR-1 can increase AR levels, leading to hair loss in men.

AH-001 could be a safer and more effective treatment for hair loss.

DHT enhances androgen receptor activity more than testosterone, and MAGE-11 influences this activity through specific interactions.

A new treatment for hair loss shows promise with fewer side effects.

Mutations at Val-889 and Arg-752 disrupt key interactions in the androgen receptor, affecting its function.

Researchers developed new compounds that target the androgen receptor effectively with fewer side effects.

CAG repeat polymorphism and prostate zone volume are not reliable markers of long-term androgen sensitivity.

A point mutation in the androgen receptor gene causes complete androgen insensitivity.

Blocking DHT production more strongly may help control advanced prostate cancer and improve quality of life.

Finasteride changes androgen receptor location in rat epididymis without altering tissue structure.

Spironolactone reduces the number of androgen receptor sites in rat skin by blocking them with its metabolite.

The study concludes that a genetic mutation in TFM mice leads to reduced androgen receptor activity, affecting the body's response to male hormones.

Interleukin‐1 α reduces androgen receptor levels and increases certain cytokines in human scalp cells.

Clascoterone may be an effective topical treatment for hair loss.